Question · Q4 2025
Davis Sunderland asked about the potential for General Rate Case (GRC) delays to become a new norm, seeking confidence in future cases staying on track. He also inquired about the regulatory environments and key mechanisms in Oregon and Nevada, including anticipated capital expenditure investments. Additionally, he requested an update on the EPA's PFAS pushout, the company's plans, and the status of class action suit recoveries.
Answer
Greg Milleman (VP of Rates and Regulatory Affairs Officer) and Marty Kropelnicki (Chairman, President and CEO) addressed the GRC delays, noting increased commission focus on timely decisions, active communication, and the immediate 3% interim rate increase. They highlighted Commissioner Matt Baker's commitment to timely outcomes due to affordability concerns. For Oregon and Nevada, Greg detailed hybrid rate-making, DSIC in Nevada, construction work in progress (CWIP) in Oregon, and efficient 6-month rate case processes. Marty estimated initial CapEx of $20M-$30M for the acquired systems, with future growth opportunities. Regarding PFAS, Marty affirmed the company's commitment to proceed with treatment plans, having spent $20M in 2025 and projecting $50M-$70M in 2026, irrespective of federal delays, emphasizing water quality. James Lynch (SVP, CFO and Treasurer) clarified that the $235M PFAS spend includes treatment (mostly by end of 2027) and new wells (longer permitting).
Ask follow-up questions
Fintool can predict
CWT's earnings beat/miss a week before the call

